Quantcha now offering unlimited commission-free options trading.
Quantchabot has detected a promising Synthetic Long Stock trade opportunity for CLOVIS ONCOLOGY (CLVS) for the 17-Apr-2020 expiration period. You can analyze the opportunity in depth over at the Quantcha Options Search Engine.
CLVS was recently trading at $9.92 and has an implied volatility of 72.10% for this period. Based on an analysis of the options available for CLVS expiring on 17-Apr-2020, there is a 68.27% likelihood that the underlying will close within the analyzed range of $4.53-$22.07 at expiration. In this scenario, the average linear return for the trade would be 66.12%.
Upside potential: This synthetic long position offers the same potential benefits and liabilities as a long stock position, but at a discount due to the significant premium at-the-money puts are trading at over calls. In this case, the put position is opened at a strike of $10.00, which is already $0.08 in-the-money. However, its sale more than offsets this moneyness and the cost of the long call that the trade results in a net credit of of $1.65 per share. The final position can be considered as having a discount of $1.57 per share over the underlying price of $9.92 for a 15.83% total.
Downside risk: This discount is generally a sign of the stock facing considerable short pressure, and may indicate that the stock has become hard to borrow. However, if you have a long view of the underlying over this period, it could be a good opportunity to benefit from the upside at a major discount.
To analyze this trade in depth, please visit the Quantcha Options Search Engine.
This is an automated post generated based on a market analysis of delayed data at 11/26/2019 10:37:24 AM ET. The analysis does not include brokerage fees or commissions and is not investment advice.